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Background: Desquamative interstitial pneumonia is a rare form of interstitial lung disease in children. Respiratory
symptoms appear progressively, are often subtle, and diagnosis is often delayed by a mean of 6 months after onset.
High resolution chest computed tomography is the most sensitive imaging technique for demonstrating and
identifying interstitial pneumonia. The typical histologic pattern of desquamative interstitial pneumonia, with
prominent clustered alveolar macrophages, diffuse reactive alveolar epithelial hyperplasia and globular
proteinaceous material, is diagnostic. Desquamative interstitial pneumonia in children can be idiopathic, though it is
mostly related to an inborn error of surfactant metabolism.
Case presentation: We present the complex clinical course and pathologic findings of a 30-months-old Mauritian
and Senegalese girl with idiopathic desquamative interstitial pneumonia and multiple extrapulmonary manifestations.
To our knowledge, this is the first case report of desquamative interstitial pneumonia to occur as part of a syndrome
with multiple organ involvement.
Conclusion: We believe that desquamative interstitial pneumonia is not always associated with mutations of the
surfactant proteins, and can still be idiopathic, especially when occurring as part of a syndrome with multiple organ
involvement, as described in other interstitial lung diseases.
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Multiorgan involvementBackground
Pediatric interstitial lung disease is a heterogeneous group
of rare and diffuse lung di22333seases [1] with chronic re-
spiratory symptoms and a negative impact on growth. It is
less frequent in children than in adults, and differs consid-
erably in its etiology and pathogenesis [2,3]. For example,
desquamative interstitial pneumonia (DIP) occurs in both
age groups but has different pathophysiologies. It is re-
lated to prolonged smoking in adults, whereas in children
it can be idiopathic, but is mostly related to an inborn
error of surfactant metabolism [4].
We describe a case of a child with idiopathic DIP diag-
nosed at almost 3 years of age who also presents multiple
dermatologic, renal, electrolyte, neurologic, growth and de-
velopmental abnormalities since infancy. To our know-
ledge, this is the first case report to suggest that DIP can* Correspondence: sabrina.bressieux-degueldre@chuv.ch
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article, unless otherwise stated.occur as part of a syndrome with multiple extrapulmonary
manifestations, as previously described for other interstitial
lung diseases [2].
Case presentation
A 30-months-old girl was referred to our pediatric pulmo-
nology clinic because of persistent respiratory distress and
hypoxemia. Her past medical history revealed multiple cu-
taneous, renal, electrolyte, growth and developmental
anomalies. She was born at term to a Mauritian mother
and a Senegalese father, and her clinical course was marked
by recurrent episodes of hyponatremia with secondary sei-
zures, caused by a nephrogenic syndrome of inappropriate
antidiuretic hormone secretion (SIADH) type C. She also
had recurrent urinary tract infections, a bronchopneumonia
at 3 months of age, failure to thrive, developmental delay,
as well as abnormal skin pigmentation and café-au-lait
spots. A full work-up excluded cystic fibrosis, cellular and
humoral immune deficiencies, tuberous sclerosis and mito-
chondrial disorders. She had a normal karyotype and array-Med Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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showed no mutations in the aquaporine AQP2 and
AVPR2 genes.
She was initially admitted to a regional hospital for
suspected aspiration pneumonia. Despite 3 weeks of co-
amoxicilline, her tachypnea, cough, respiratory distress
and oxygen requirement persisted. Her physical exam-
ination revealed a respiratory rate of 42/min, a trans-
cutaneous oxygen saturation of 92% on 1.5 L/min of
supplemental oxygen by nasal cannula, retractions and
fine expiratory crackles at the right apex and both
bases with bronchial breath sounds on the right basal
lung field. Cardiac examination was normal and there
was no clubbing. Further findings included discolored
fine hair, hyper- and hypopigmented macules, and
café-au-lait spots over an extremely dry, thick and
scaly dark skin.
Chest radiographs consistently showed multiple right-
sided confluent infiltrates with air-bronchograms and a
normal heart size. In the absence of pulmonary hyperten-
sion and cardiac malformations, chronic pulmonary disease
was considered. She underwent a chest high resolution
computed tomography (HRCT), which showed diffuse
ground-glass lung opacities (GGO) without bronchiectasis
(Figure 1).
A bronchoscopy and a lung biopsy via thoracoscopy
were also performed. The bronchoalveolar lavage (BAL)
showed increased cellularity with 30% lymphocytes
(CD4/CD8 ratio 1.4), 45% neutrophils, and macrophagic
clusters but no lipid-laden macrophages. Immunohisto-
chemistry for histiocytosis was negative, but the presence
of periodic acid-Schiff (PAS) material suggested alveolarFigure 1 Chest computerized tomography scan showing diffuse grou
the left lower lobe.proteinosis (PAP). However, the lung biopsy from the
right upper lobe in an area of GGO did not confirm PAP.
Instead, it showed macrophages completely filling the al-
veolar spaces, preserved pulmonary architecture, focal
hyperplasia of type II pneumocytes, and fibrous thickening
of alveolar septae with a monocytic inflammatory infil-
trate, confirming desquamative interstitial pneumonia
(DIP) (Figure 2). Both BAL and the biopsy were sterile.
Since DIP is most commonly related to abnormal surfac-
tant metabolism in children, genetic analysis for the most
frequent protein mutations was performed. There were no
mutations found in the deoxyribonucleic acid (DNA) se-
quencing of the ABCA3 gene or in the sequence analysis
of the surfactant protein C gene.
Following the diagnosis of DIP, the patient was treated
with systemic corticosteroids (2mg/kg/day for 10 days
then 1mg/kg/day for 1 month) and co-trimoxazole for
Pneumocystis prophylaxis. Due to a poor clinical re-
sponse with persistent respiratory distress and several
episodes of hypoxemic malaise, hydroxychloroquine at
8mg/kg/day was added and replaced one month later by
azathioprine at 2mg/kg/day due to lack of improvement.
After 2 years of treatment, the patient is still oxygen-
dependent, tolerating brief daily pauses. Her dyspnea and
exercise tolerance have improved slightly as she has had
no further episodes of hypoxemic malaise, and she im-
proved her walking distance on the 6-minute walk test.
She hasn’t started school yet but is doing well in day care.
Discussion
Desquamative interstitial pneumonia (DIP) is the
most frequently described histologic diagnosis amongstnd-glass opacities with air-bronchograms in the upper lobes and
Figure 2 The alveolar architecture is preserved and delimited by a fibrous thickening (blue) of alveolar walls. Within these septae, slight
mononuclear infiltrates may be seen. Alveolar spaces are filled with macrophages (red) (Trichroma, 200×).
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initially reported [5], but it is now mostly recognized
as the consequence of a genetic defect in surfactant
proteins.
Our patient presented with a uniquely complex medical
history including renal, electrolyte, neurologic, dermato-
logic, growth, developmental and pulmonary anomalies.
Except for nephrogenic SIADH type C, no specific disease
was identified. Respiratory symptoms progressed insidiously
and DIP was diagnosed 4 months after their initial appear-
ance. As described in most forms of chronic interstitial lung
disease in children, respiratory symptoms appear progres-
sively and are often subtle, with a mean duration of at least
6 months before diagnosis [3]. Cough, tachypnea and
dyspnea occur in most patients, whereas failure to thrive
is more frequent in small children. The presence of these
symptoms for more than 3 months should prompt specific
evaluation for interstitial disease following a systematic
approach [3,4].
Among ancillary tests, high resolution computed tom-
ography of the chest is the most sensitive imaging tech-
nique for demonstrating interstitial pneumonia. Its
findings may be specific for or highly suggestive of a pre-
cise diagnosis [6]. Furthermore, HRCT provides import-
ant information on the extent and severity of the
disease. In our patient, the presence of ground glass
opacities combined with a “crazy-paving” pattern led to
a high suspicion of an inborn error of surfactant metab-
olism as this pattern is typically associated with PAP [6].
In addition, it helped the surgeon in selecting the appro-
priate lung area for biopsy.Likewise, bronchoalveolar lavage showed PAS positive
material compatible with PAP. It contributed in exclud-
ing aspiration, infection, and histiocytosis as there were
no lipid laden macrophages, all cultures and viral studies
were negative, and CD1a coloration was negative. The
subsequent histologic examination of the lung biopsy
obtained by thoracoscopy did not support PAP, but in-
stead confirmed DIP with prominent clustered alveolar
macrophages, diffuse reactive alveolar epithelial hyper-
plasia and globular proteinaceous material, an histologic
pattern mostly related to surfactant metabolism dysfunc-
tion. However, no mutations were found in the deoxy-
ribonucleic acid (DNA) sequencing of the ABCA3 and
SFTPC genes in our patient, and thyroid function was
normal, excluding a TTF1 mutation. Furthermore, elec-
tronic microscopy of the lung biopsy revealed normal la-
mellar bodies, making surfactant dysfunction unlikely.
We therefore concluded that this was idiopathic DIP. In-
deed, a small subset of patients with histologic features
of genetic disorders of surfactant metabolism and nor-
mal genetic testing has been described, representing an
area of active investigation [2].
There are very few publications on the co-existence of
DIP and extrapulmonary manifestations. A previous re-
port by Sheth et al. [7] described a patient with DIP and
nephrotic syndrome due to focal segmental glomerulo-
sclerosis with an immunologically mediated pathogen-
esis. In our case, immunoglobulins, serum complement
levels and lymphocytic subtypes were all normal. An-
other report describes the development of DIP following
prolonged treatment with nitrofurantoin [8]. In our case,
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nary manifestations. Lastly, the entity termed Reunion
Island pulmonary alveolar proteinosis [9] was also excluded
as it did not correspond to our patient’s ethnicity and her
histologic diagnosis.
Treatment of pediatric interstitial lung disease, including
DIP, is mainly supportive with aggressive nutritional inter-
vention and prevention of infections [4]. Many children
with advanced disease require supplemental oxygen ther-
apy either at night or continuously, as was the case in our
patient. Since inflammation plays an important role, corti-
costeroids and immunosuppressive drugs can be used but
no clinical trial has proven their efficacy, and prognosis re-
mains poor despite treatment [10]. Lung transplantation
becomes an option when there is progression to end-stage
disease.
In our case, several treatment options were tried,
with clinical improvement achieved with low dose
prednisone and azathioprinein conjunction with con-
tinuous oxygen therapy. So far, lung transplantation
has not been considered.
Conclusion
DIP is most commonly related to surfactant protein dys-
function but may be of unclear origin, especially when
associated with other organ involvement. In fact, it can
occur as part of a syndrome with multiple organ involve-
ment, as described in other interstitial lung diseases.
However, the relationship between chronic respiratory
disease and multiorgan involvement is currently not well
understood.
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